About 40 million Americans are on statins. Most are middle-aged men, which overlaps heavily with the demographic that develops acquired premature ejaculation. The standard narrative is that statins lower cardiovascular risk with minimal side effects. That's mostly true. But there's a hormonal pathway that doesn't get enough attention, and it's directly connected to ejaculatory function.
Cholesterol is not just dietary noise. It's a precursor molecule. Every steroid hormone in your body, including testosterone, is synthesized from cholesterol. Block cholesterol synthesis and you don't only reduce LDL. You reduce the substrate available for steroid hormone production.
The Cholesterol-Testosterone Chain
The pathway goes like this: dietary and endogenously produced cholesterol is converted to pregnenolone, which branches into the steroid hormone pathways, eventually producing testosterone via a series of enzymatic steps in the testes and adrenal glands.
HMG-CoA reductase inhibitors (statins) work by blocking the enzyme that synthesizes mevalonate, an early step in cholesterol production. This reduces total cholesterol, including the LDL that contributes to atherosclerosis. It also reduces the cholesterol available for steroidogenesis.
The clinical evidence is mixed and the effect size varies considerably by individual, statin type, and dose. But studies have documented measurable reductions in total testosterone in men on statins, with some meta-analyses finding mean reductions in the range of 10-20%. For a man at the lower end of normal testosterone range already, that reduction has real effects.
What Lower Testosterone Does to Ejaculatory Function
This requires some nuance, because testosterone and PE aren't simply inversely correlated. High testosterone doesn't directly protect against PE and low testosterone doesn't directly cause it. The picture is more complicated.
Testosterone influences libido, the intensity of arousal, erection quality, and the sensitivity calibration of the ejaculatory system. When testosterone drops, several things tend to happen. Baseline arousal decreases. The ejaculatory system, still capable of triggering the reflex, does so with less of the gradual escalation that gives you time to regulate. The ramp-up from low arousal to ejaculation gets compressed because the initial arousal foundation is weaker.
There's also an interaction with serotonin. Testosterone modulates serotonin receptor sensitivity. Serotonin inhibits the ejaculatory reflex, which is why SSRIs delay ejaculation. Lower testosterone can reduce serotonergic tone, which lowers the ejaculatory threshold even if there's no direct testosterone-PE pathway being activated.
The practical result for some men is that a statin-induced testosterone reduction doesn't cause PE from scratch, but it tips a marginally controlled system into an uncontrolled one. A man who was managing his PE adequately finds it getting noticeably worse six months after starting a statin. He doesn't connect the dots because no one told him the mechanism exists.
The Side Effect Nobody Mentions
Statins are generally well tolerated. The most discussed side effect is myopathy, muscle pain and weakness, which occurs in a meaningful minority of patients. Sexual side effects, including reduced libido, erectile changes, and ejaculatory changes, are less commonly discussed but appear in patient-reported outcome data more often than clinical trial publications suggest.
Part of the reason is methodological: clinical trials for statins weren't designed to measure ejaculatory latency. Patients don't always report sexual changes to their prescribing physician, and physicians don't always ask. The result is a gap in the documented evidence that doesn't mean the effect isn't real.
If you're on a statin and you've noticed your PE worsening, or acquired PE developing where it didn't previously exist, the mechanism exists for this to be connected. It's worth raising with your prescribing doctor. There are multiple statins with different pharmacological profiles, and some have less impact on hormonal pathways than others. A testosterone panel might be informative.
This is not an argument against statins. Cardiovascular risk is serious and statins have prevented a lot of heart attacks. But managing the side effects, including the ones that don't get discussed, is a legitimate part of the treatment conversation.
What This Means for Your Training
Whether or not statins are your specific variable, the downstream effects described above point to the same training targets.
If your ejaculatory control problem is partly driven by a compressed arousal ramp, meaning you go from low arousal to ejaculation with less warning than you should have, arousal awareness work is central. This means developing a precise internal sense of where you are on your arousal scale at any given moment, and building the skill to intervene at 6 or 7 out of 10 rather than noticing you're at 9 and already past the point of no return.
This is one of the six PE factors that Control: Last Longer's assessment covers. Poor arousal awareness is extremely common, and it's particularly pronounced in men whose arousal ramp is compressed for any reason, hormonal, neurological, or situational.
The edging practice in a structured protocol is specifically designed to build this awareness. You're training your nervous system to hold high arousal states without reflexively discharging them, and in doing so you develop a finer-grained map of your own arousal escalation. You start to notice earlier, catch it sooner, and have more real options.
Pelvic floor work matters here too. If the ejaculatory reflex is firing with a compressed warning window, having better pelvic floor regulation, the ability to consciously release tension rather than let it build to discharge, adds a second layer of intervention.
The Bigger Point About Acquired PE
Most men with acquired PE, PE that developed after a period of adequate control, have a cause that is identifiable if you look for it. Post-viral autonomic changes. Hormonal shifts. Medication side effects. Relationship stress. Conditioning from infrequent sex.
Statins are one of the more underrecognized items on that list. Not because the effect is dramatic or universal, but because the mechanism is real, the population overlap is large, and no one is actively connecting the dots in a clinical setting.
Understanding that your ejaculatory control change might have a specific, identifiable cause is useful. It reframes the problem from a vague dysfunction that just appeared to a downstream consequence of something specific. That reframe is practically important because it tells you what to address, and it removes the self-blame that tends to compound the psychological load that makes PE worse.
You're probably not broken. Your cholesterol medication is probably nudging a system that was already borderline. That's a manageable problem with a trainable solution.